Verla-Pharm Arzneimittel & Co.
Verla-Pharm Arzneimittel & Co. Technographics
Verla-Pharm Arzneimittel & Co. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Verla-Pharm Arzneimittel & Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 268 Verla-Pharm Arzneimittel & Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Verla-Pharm Arzneimittel & Co. has purchased the following applications: Cisco Webex Meetings for Audio Video and Web Conferencing in 2020, DHC Vision for Quality Management in 2020, Acenet Ace-Host Cloud for Application Hosting and Computing Services in 2013 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Verla-Pharm Arzneimittel & Co. is running and its propensity to invest more and deepen its relationship with Cisco Systems , DHC Business Solutions , Acenet or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Verla-Pharm Arzneimittel & Co. revenues, which have grown to $69.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Verla-Pharm Arzneimittel & Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Verla-Pharm Arzneimittel & Co. Tech Stack and Enterprise Applications
Verla-Pharm Arzneimittel & Co. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Cisco Systems | Legacy | Cisco Webex Meetings | Audio Video and Web Conferencing | Collaboration | n/a | 2020 | 2020 |
In 2020, Verla-Pharm Arzneimittel & Co. deployed Cisco Webex Meetings for Audio Video and Web Conferencing to standardize virtual collaboration across its German operations. The deployment established Cisco Webex Meetings as the primary conferencing platform for scheduled and ad hoc internal and external meetings, aligning with the companys lifecycle and regulatory communication needs in the life sciences sector.
The implementation covered core functional modules typical of the Audio Video and Web Conferencing category, including multi-party video meetings, HD audio, screen sharing, meeting recording and playback, host controls and participant management, and built-in security and access controls. Configuration focused on meeting templates, role based host privileges, and centralized recording retention settings to support consistent meeting governance across teams.
Architecturally the deployment used Cisco Webex Meetings cloud services with tenant level administration and endpoint interoperability to support desktop and room systems across sites in Germany. Operational coverage extended company wide, enabling collaboration between scientific, regulatory and commercial functions while consolidating meeting infrastructure under a single vendor platform.
Governance and rollout were organized through centralized IT administration with phased user onboarding, standardized meeting policies, and administrator level controls for user provisioning and compliance monitoring. Training and adoption activities were aligned with routine operational workflows to minimize disruption to regulated processes and ensure consistent use of Cisco Webex Meetings for Audio Video and Web Conferencing.
|
Verla-Pharm Arzneimittel & Co. PLM and Engineering
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DHC Business Solutions | Legacy | DHC Vision | Quality Management | PLM and Engineering | n/a | 2020 | 2020 |
In 2020, Verla-Pharm Arzneimittel & Co. implemented DHC Vision, adopting the Quality Management application to modernize and digitalize regulated quality processes across its pharmaceutical operations in Germany. The rollout targeted regulated workflows including deviation management, complaint management, change control, SOP management, and training management to centralize control of quality activities.
The deployment configured DHC Vision modules for deviation, complaint and change management alongside SOP and training management, aligning functional workflows with pharmaceutical compliance requirements. DHC Business Solutions delivered validation templates as part of the implementation to accelerate validation tasks and reduce manual effort associated with regulatory documentation.
The DHC case study reports closer ERP and MES integration to improve quality data flow between manufacturing execution and enterprise systems, enabling tighter orchestration of manufacturing events and quality cases. Operational coverage emphasized QA and manufacturing process touchpoints, consolidating quality records and incident handling within the DHC Vision environment.
Governance changes focused on standardized and automated quality processes, with workflow enforcement and controlled document management to support auditability and compliance. The implementation delivered standardized process automation and validation artifacts that the vendor reported as accelerating compliance and reducing manual effort.
|
Verla-Pharm Arzneimittel & Co. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Acenet | Legacy | Acenet Ace-Host Cloud | Application Hosting and Computing Services | IaaS | n/a | 2013 | 2013 |
In 2013, Verla-Pharm Arzneimittel & Co. implemented Acenet Ace-Host Cloud as its Application Hosting and Computing Services platform. The deployment centralized hosting for core business applications supporting IT operations and production systems at the Germany-based life sciences company.
Acenet Ace-Host Cloud provided a hosted cloud architecture with virtualized compute instances, block and file storage, snapshot-based backup, and centralized monitoring and alerting. The platform functioned as an application hosting and compute layer delivering operating system provisioning, capacity scaling, and managed runtime environments for server-side applications.
Implementation covered standard hosting capabilities including compute provisioning, storage management, network segmentation, and baseline security controls such as access management and logging. Connectivity was established to Verla-Pharm's internal IT environment to support enterprise authentication and data exchange with on-premises applications.
Operational governance emphasized centralized IT control for provisioning, change management, monitoring, and incident response, consolidating hosting requests through the company's IT operations team. Rollout was oriented to support business functions across the German sites and to standardize application hosting practices under the Application Hosting and Computing Services model.
|
 |
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Verla-Pharm Arzneimittel & Co.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Verla-Pharm Arzneimittel & Co. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Verla-Pharm Arzneimittel & Co. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Verla-Pharm Arzneimittel & Co. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Verla-Pharm Arzneimittel & Co. Technographics
Verla-Pharm Arzneimittel & Co. is a Life Sciences organization based in Germany,
with around 268 employees and annual revenues of $69.0 million.
Verla-Pharm Arzneimittel & Co. operates a diverse technology stack with applications such as
Cisco Webex Meetings, DHC Vision and Acenet Ace-Host Cloud,
covering areas like Audio Video and Web Conferencing, Quality Management and Application Hosting and Computing Services.
Verla-Pharm Arzneimittel & Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Cisco Systems, DHC Business Solutions and Acenet.
Verla-Pharm Arzneimittel & Co. recently adopted applications including
Cisco Webex Meetings in 2020, DHC Vision in 2020 and Microsoft Azure Cloud Services in 2020,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Verla-Pharm Arzneimittel & Co.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Verla-Pharm Arzneimittel & Co.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Verla-Pharm Arzneimittel & Co. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.